Cargando…
Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer
For all of the optimism that immunotherapy has engendered, the flip side is that 7/10 patients with susceptible tumor types do not respond, while in nonsusceptible tumor types the response rates are significantly lower. In contradiction of the current orthodoxy against surgery in the setting of unre...
Autores principales: | Oronsky, Bryan, Larson, Chris, Reid, Tony R., Carter, Corey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069027/ https://www.ncbi.nlm.nih.gov/pubmed/30083560 http://dx.doi.org/10.1177/2324709618786319 |
Ejemplares similares
-
Extended treatment with MY-NEOVAX, personalized neoantigen-enhanced oncolytic viruses, for two end-stage cancer patients
por: Bouvet, Michael, et al.
Publicado: (2019) -
A Local and Abscopal Effect Observed with Liposomal Encapsulation of Intratumorally Injected Oncolytic Adenoviral Therapy
por: Dong, Tao, et al.
Publicado: (2023) -
What's New in SCLC? A Review
por: Oronsky, Bryan, et al.
Publicado: (2017) -
Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy
por: Oronsky, Bryan, et al.
Publicado: (2016) -
Abscopal effect in the radio and immunotherapy
por: Pevzner, Alina M., et al.
Publicado: (2021)